Nova Leap Health Corp. places No. 2 on The Globe and Mail’s second-annual ranking of Canada’s Top Growing Companies
25 Setembro 2020 - 10:01AM
NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”),
a 2019 TSX Venture 50™ ranked company focused on the home health
care industry, is pleased to announce that it placed No. 2 on the
2020 Report on Business ranking of Canada’s Top Growing Companies.
Canada’s Top Growing Companies ranks Canadian
companies on three-year revenue growth. Nova Leap earned its spot
with three-year growth of 8,602%.
“This ranking, and our growth, is a reflection
of tremendous dedication by our staff in service of those that
require care in the home”, said Chris Dobbin, President & CEO
of Nova Leap. “Our commitment to serve those living with dementia
continues as we enter our next phase of growth.”
About Canada’s
Top Growing Companies
Launched in 2019, the Canada’s Top Growing
Companies editorial ranking aims to celebrate entrepreneurial
achievement in Canada by identifying and amplifying the success of
growth-minded, independent businesses in Canada. It is a voluntary
program; companies had to complete an in-depth application process
in order to qualify. In total, 400 companies earned a spot on this
year’s ranking.
The full list of 2020 winners, and accompanying
editorial coverage, is published in the October issue of Report on
Business magazine—out now—and online at tgam.ca/TopGrowing.
“The stories of Canada’s Top Growing Companies
are worth telling at any time, but are especially relevant in the
wake of COVID-19 pandemic,” says James Cowan, Editor of Report on
Business magazine. “As businesses work to rebuild the economy,
their resilience and innovation make for essential reading.”
“Any business leader seeking inspiration should
look no further than the 400 businesses on this year’s Report on
Business ranking of Canada’s Top Growing Companies,” says Phillip
Crawley, Publisher and CEO of The Globe and Mail. “Their growth
helps to make Canada a better place, and we are proud to bring
their stories to our readers.”
About Nova Leap
Nova Leap is an acquisitive home health care
services company operating in one of the fastest-growing industries
in the U.S. & Canada. The Company performs a vital
role within the continuum of care with an individual and family
centred focus, particularly those requiring dementia care. Nova
Leap achieved the #10 Ranking in the 2019 TSX Venture 50™ in the
Clean Technology & Life Sciences sector. The Company is
geographically diversified with operations in 7 different U.S.
states within the New England and South- Central regions as well as
Nova Scotia, Canada.
About The
Globe and Mail
The Globe and Mail is Canada’s foremost news
media company, leading the national discussion and causing policy
change through brave and independent journalism since 1844. With
award-winning coverage of business, politics and national affairs,
The Globe and Mail newspaper reaches 5.9 million readers every week
in print or digital formats, and Report on Business magazine
reaches 2.1 million readers in print and digital every issue. The
Globe and Mail’s investment in innovative data science means that
as the world continues to change, so does The Globe. The Globe and
Mail is owned by Woodbridge, the investment arm of the Thomson
family.
FORWARD LOOKING
INFORMATION:
Certain information in this press release may
contain forward-looking statements, such as statements regarding
future expansions and cost savings, the Company’s expected
annualized recurring revenue run rate and plans regarding future
acquisitions and financings. This information is based on current
expectations and assumptions, including assumptions concerning
general economic and market conditions, availability of working
capital necessary for conducting Nova Leap’s operations, and Nova
Leap’s ability to integrate its acquired businesses and maintain
previously achieved service hour and revenue levels, that are
subject to significant risks and uncertainties that are difficult
to predict. Actual results might differ materially from results
suggested in any forward-looking statements. Risks that could cause
results to differ from those stated in the forward-looking
statements in this release include the impact of the COVID-19
pandemic or any recurrence, including government regulations or
voluntary measures limiting the Company’s ability to provide care
to clients (such as shelter-in-place orders, isolation or
quarantine orders, distancing requirements, or closures or
restricted access procedures at facilities where clients reside),
increased costs associated with personal protective equipment and
sanitization supplies, staff and supply shortages; regulatory
changes affecting the home care industry, other unexpected
increases in operating costs and competition from other service
providers. All forward-looking statements, including any financial
outlook or future-oriented financial information, contained in this
press release are made as of the date of this release and included
for the purpose of providing information about management's current
expectations and plans relating to the future. The Company assumes
no obligation to update the forward-looking statements, or to
update the reasons why actual results could differ from those
reflected in the forward-looking statements unless and until
required by securities laws applicable to the Company. Additional
information identifying risks and uncertainties is contained in the
Company's filings with the Canadian securities regulators, which
filings are available at www.sedar.com.
CAUTIONARY STATEMENT:
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
For further information:
Chris Dobbin, CPA, CA
Director, President and CEO
Nova Leap Health Corp.
T: 902 401 9480 F: 902 482 5177
E: cdobbin@novaleaphealth.com
Nova Leap Health (TSXV:NLH)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Nova Leap Health (TSXV:NLH)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025